Filed: 11/10/2022ACC: 0000950123-22-011472
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $58.7K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$58.7K
Total AUM (reported)
18.73M
Total Shares
Allocation by class
COMMON SHARES$32.6K55.5%
COMMON STOCK$26.1K44.5%
Portfolio Concentration
Top 3$47.9K81.7%
4–10$10.7K18.3%
Top 3 weight
81.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 18.73M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
18.73M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other8
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings8
Rows:
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$32.6K
55.55%
Sole
0.00
Shared
498.56K
None
0.00
Gritstone Oncology, Inc.
OTRShares3.56M
TypeSH
Market value$9.2K
15.60%
Sole
0.00
Shared
3.56M
None
0.00
Passage Bio, Inc.
OTRShares4.96M
TypeSH
Market value$6.2K
10.57%
Sole
0.00
Shared
4.96M
None
0.00
Adverum Biotechnologies, Inc.
OTRShares5.07M
TypeSH
Market value$4.8K
8.21%
Sole
0.00
Shared
5.07M
None
0.00
Aligos Therapeutics, Inc.
OTRShares2.32M
TypeSH
Market value$2.6K
4.35%
Sole
0.00
Shared
2.32M
None
0.00
CymaBay Therapeutics, Inc.
OTRShares543.75K
TypeSH
Market value$1.9K
3.24%
Sole
0.00
Shared
543.75K
None
0.00
Minerva Surgical Inc.
OTRShares1.67M
TypeSH
Market value$1.3K
2.27%
Sole
0.00
Shared
1.67M
None
0.00
Clovis Oncology, Inc.
OTRShares101.86K
TypeSH
Market value$121.00
0.21%
Sole
0.00
Shared
101.86K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $32.6K 55.55% | 0.00 | 498.56K | 0.00 |
Gritstone Oncology, Inc.OTR | Common Stock | 3.56M | SH | $9.2K 15.60% | 0.00 | 3.56M | 0.00 |
Passage Bio, Inc.OTR | Common Stock | 4.96M | SH | $6.2K 10.57% | 0.00 | 4.96M | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 5.07M | SH | $4.8K 8.21% | 0.00 | 5.07M | 0.00 |
Aligos Therapeutics, Inc.OTR | Common Stock | 2.32M | SH | $2.6K 4.35% | 0.00 | 2.32M | 0.00 |
CymaBay Therapeutics, Inc.OTR | Common Stock | 543.75K | SH | $1.9K 3.24% | 0.00 | 543.75K | 0.00 |
Minerva Surgical Inc.OTR | Common Stock | 1.67M | SH | $1.3K 2.27% | 0.00 | 1.67M | 0.00 |
Clovis Oncology, Inc.OTR | Common Stock | 101.86K | SH | $121.00 0.21% | 0.00 | 101.86K | 0.00 |